FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896539080> ?p ?o ?g. }

• W2896539080 endingPage "155" @default.
• W2896539080 startingPage "148" @default.
• W2896539080 abstract "Male osteoporosis can occur with advanced age and with hypogonadism, with increased bone resorption and/or inadequate bone formation contributing to reduced bone mass and increased fracture risk. Abaloparatide is a selective PTH receptor agonist that increases bone formation and bone mass in postmenopausal women with osteoporosis and in estrogen-deficient animals. The current study evaluated the effects of abaloparatide in orchiectomized (ORX) rats, a model of male osteoporosis. Four-month-old Sprague-Dawley rats underwent ORX or sham surgery; 8 weeks later the ORX groups exhibited relative osteopenia vs sham controls, based on dual X-ray absorptiometry (DXA) and/or peripheral quantitative computed tomography (pQCT) assessments at the total body, lumbar spine, femur, and tibia. ORX rats (n = 10/group) were then injected daily (s.c.) for 8 weeks with vehicle or abaloparatide at 5 (ABL5) or 25 μg/kg/d (ABL25). Sham controls (n = 10) received s.c. vehicle. DXA and pQCT showed that one or both abaloparatide groups gained more areal and volumetric BMD at all sites analyzed compared with vehicle controls, leading to substantial or complete reversal of ORX-induced BMD deficits. pQCT also indicated greater gains in tibial cortical thickness in both abaloparatide groups versus vehicle controls. Tibial bone histomorphometry showed greater trabecular bone formation and bone volume and improved micro-architecture with abaloparatide, with no increase in osteoclasts. Abaloparatide also led to significant improvements in the balance of biochemical bone formation markers versus bone resorption markers, which correlated with BMD changes. These findings suggest that abaloparatide may have therapeutic benefits in men with osteoporosis." @default.
• W2896539080 created "2018-10-26" @default.
• W2896539080 creator A5002821564 @default.
• W2896539080 creator A5018227601 @default.
• W2896539080 creator A5018506014 @default.
• W2896539080 creator A5042999308 @default.
• W2896539080 creator A5050834802 @default.
• W2896539080 creator A5053072500 @default.
• W2896539080 creator A5056376224 @default.
• W2896539080 creator A5060381803 @default.
• W2896539080 creator A5060966803 @default.
• W2896539080 creator A5062845949 @default.
• W2896539080 creator A5075226333 @default.
• W2896539080 creator A5083340084 @default.
• W2896539080 date "2019-03-01" @default.
• W2896539080 modified "2023-09-24" @default.
• W2896539080 title "Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption" @default.
• W2896539080 cites W1964577685 @default.
• W2896539080 cites W1968485175 @default.
• W2896539080 cites W1988082260 @default.
• W2896539080 cites W1989880575 @default.
• W2896539080 cites W1992121694 @default.
• W2896539080 cites W1997732940 @default.
• W2896539080 cites W1999311566 @default.
• W2896539080 cites W2001406070 @default.
• W2896539080 cites W2011011117 @default.
• W2896539080 cites W2013724724 @default.
• W2896539080 cites W2030784208 @default.
• W2896539080 cites W2033754501 @default.
• W2896539080 cites W2036051320 @default.
• W2896539080 cites W2045805069 @default.
• W2896539080 cites W2073861563 @default.
• W2896539080 cites W2077611949 @default.
• W2896539080 cites W2082229075 @default.
• W2896539080 cites W2083011022 @default.
• W2896539080 cites W2085086344 @default.
• W2896539080 cites W2088866528 @default.
• W2896539080 cites W2096425957 @default.
• W2896539080 cites W2110396808 @default.
• W2896539080 cites W2114448119 @default.
• W2896539080 cites W2128302145 @default.
• W2896539080 cites W2144000500 @default.
• W2896539080 cites W2159635135 @default.
• W2896539080 cites W2516614130 @default.
• W2896539080 cites W2538948868 @default.
• W2896539080 cites W2553823910 @default.
• W2896539080 cites W2583623004 @default.
• W2896539080 cites W2595047833 @default.
• W2896539080 cites W2775903390 @default.
• W2896539080 cites W4244116245 @default.
• W2896539080 doi "https://doi.org/10.1016/j.bone.2018.10.012" @default.
• W2896539080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30343166" @default.
• W2896539080 hasPublicationYear "2019" @default.
• W2896539080 type Work @default.
• W2896539080 sameAs 2896539080 @default.
• W2896539080 citedByCount "27" @default.
• W2896539080 countsByYear W28965390802018 @default.
• W2896539080 countsByYear W28965390802019 @default.
• W2896539080 countsByYear W28965390802020 @default.
• W2896539080 countsByYear W28965390802021 @default.
• W2896539080 countsByYear W28965390802022 @default.
• W2896539080 countsByYear W28965390802023 @default.
• W2896539080 crossrefType "journal-article" @default.
• W2896539080 hasAuthorship W2896539080A5002821564 @default.
• W2896539080 hasAuthorship W2896539080A5018227601 @default.
• W2896539080 hasAuthorship W2896539080A5018506014 @default.
• W2896539080 hasAuthorship W2896539080A5042999308 @default.
• W2896539080 hasAuthorship W2896539080A5050834802 @default.
• W2896539080 hasAuthorship W2896539080A5053072500 @default.
• W2896539080 hasAuthorship W2896539080A5056376224 @default.
• W2896539080 hasAuthorship W2896539080A5060381803 @default.
• W2896539080 hasAuthorship W2896539080A5060966803 @default.
• W2896539080 hasAuthorship W2896539080A5062845949 @default.
• W2896539080 hasAuthorship W2896539080A5075226333 @default.
• W2896539080 hasAuthorship W2896539080A5083340084 @default.
• W2896539080 hasConcept C126322002 @default.
• W2896539080 hasConcept C126894567 @default.
• W2896539080 hasConcept C134018914 @default.
• W2896539080 hasConcept C142724271 @default.
• W2896539080 hasConcept C146562846 @default.
• W2896539080 hasConcept C170033053 @default.
• W2896539080 hasConcept C2776541429 @default.
• W2896539080 hasConcept C2776886416 @default.
• W2896539080 hasConcept C2777083390 @default.
• W2896539080 hasConcept C2777425516 @default.
• W2896539080 hasConcept C2781451080 @default.
• W2896539080 hasConcept C673006 @default.
• W2896539080 hasConcept C71924100 @default.
• W2896539080 hasConceptScore W2896539080C126322002 @default.
• W2896539080 hasConceptScore W2896539080C126894567 @default.
• W2896539080 hasConceptScore W2896539080C134018914 @default.
• W2896539080 hasConceptScore W2896539080C142724271 @default.
• W2896539080 hasConceptScore W2896539080C146562846 @default.
• W2896539080 hasConceptScore W2896539080C170033053 @default.
• W2896539080 hasConceptScore W2896539080C2776541429 @default.
• W2896539080 hasConceptScore W2896539080C2776886416 @default.
• W2896539080 hasConceptScore W2896539080C2777083390 @default.
• W2896539080 hasConceptScore W2896539080C2777425516 @default.

• next